(1 - 22 from 25
)
Breast Cancer Updates From ESMO 2022
www.cancertherapyadvisor.com
21 Sept — ... approval,” said study discussant Meritxell Bellet Ezquerra, MD, PhD, of Vall d'Hebron Institute of Oncology in Barcelona, Spain. › home › news
New CDK4/6 Inhibitor Offers Benefits for Advanced-Stage ...
www.breastcancer.org
13 Sept — ... extension of dalpiciclib approval to the first-line metastatic breast cancer setting in the Chinese population,” Meritxell Bellet, MD, ... › research-news › new-cd...
sorted by relevance / date